Dana E. Rathkopf
- Pulmonary and Respiratory Medicine top 0.5%
- Oncology top 1%
- Molecular Biology top 5%
- Cancer Research top 1%
- Radiology, Nuclear Medicine and Imaging top 1%
- Co-authors
- Howard I. ScherPhilip W. KantoffMin Yuen TeoMichael J. MorrisDaniel C. DanilaSteven M. LarsonCelestia S. HiganoJoshi J. Alumkal
- Topics
- Prostate Cancer Treatment and Research (179 papers)Radiopharmaceutical Chemistry and Applications (99 papers)Cancer Treatment and Pharmacology (34 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Dana E. Rathkopf
191 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Pulmonary and Respiratory Medicine 3.8k
- Oncology 1.7k
- Molecular Biology 1.6k
- Cancer Research 1.4k
- Radiology, Nuclear Medicine and Imaging 1.3k
Countries citing papers authored by Dana E. Rathkopf
This map shows the geographic impact of Dana E. Rathkopf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana E. Rathkopf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana E. Rathkopf more than expected).
Fields of papers citing papers by Dana E. Rathkopf
This network shows the impact of papers produced by Dana E. Rathkopf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana E. Rathkopf. The network helps show where Dana E. Rathkopf may publish in the future.
Co-authorship network of co-authors of Dana E. Rathkopf
This figure shows the co-authorship network connecting the top 25 collaborators of Dana E. Rathkopf. A scholar is included among the top collaborators of Dana E. Rathkopf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana E. Rathkopf. Dana E. Rathkopf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 6 | |
| 7 | 1 | |
| 8 | 14 | |
| 9 | 0 | |
| 10 | 2 | |
| 11 | 20 | |
| 12 | 1 | |
| 13 | First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy | 1 |
| 14 | 61 | |
| 15 | 64 | |
| 16 | 71 | |
| 17 | 22 | |
| 18 | 1 | |
| 19 | 39 | |
| 20 | Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 studybreakdown → | 809 |
About Dana E. Rathkopf
Dana E. Rathkopf is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 203 papers that have together received 5.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (179 papers), Radiopharmaceutical Chemistry and Applications (99 papers) and Cancer Treatment and Pharmacology (34 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.8k citations), Cancer Research (1.4k citations) and Oncology (1.7k citations). Dana E. Rathkopf has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Howard I. Scher, Philip W. Kantoff, Min Yuen Teo, Michael J. Morris, Daniel C. Danila, Steven M. Larson, Celestia S. Higano, Joshi J. Alumkal, Charles J. Ryan and Martin Fleisher. Their work appears in journals such as The Lancet, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.